News

The importance of comparative effectiveness research and how to overcome its challenges.

S

The design and completeness of the protocol and early and open communication with research center personnel are factors that most influence investigative site willingness to participate in a clinical study.

Predictive Analytics for Marketing Mix: The Future is now

Protecting Subjects: The IRBs Next Steps

SITES : Incorporating Standard of Care in Study Budgets Benefits of CTMS at the Investigative Site Also in this issue : FDA Transparency Efforts to Impact Research, Survey Assesses Europe?s Clinical Trials Directive, Tapping into the Potential of Pharmacists, Biosimilars Make Headway in the U.S.

Updates on Osteoporosis including Amgen and Prolia trials.

Act cover

Do Sites Prefer a Sponsor Company or CRO to Run Their Clinical Trial?

Industry news focusing on the people and organizations who work in the clinical trials profession.